Trilogy International Partners Inc (TSE:TRL) had its target price decreased by TD Securities from C$10.50 to C$10.00 in a report released on Tuesday morning. TD Securities currently has a buy rating on the specialty pharmaceutical company’s stock.

Separately, Scotiabank reduced their price target on Trilogy International Partners from C$12.50 to C$11.00 and set an outperform rating for the company in a report on Thursday, August 10th.

Trilogy International Partners (TRL) opened at 6.95 on Tuesday. The stock has a 50 day moving average price of $7.39 and a 200 day moving average price of $8.69. Trilogy International Partners has a 1-year low of $5.46 and a 1-year high of $10.48. The company’s market cap is $307.54 million.

TRADEMARK VIOLATION NOTICE: “Trilogy International Partners Inc (TRL) PT Lowered to C$10.00 at TD Securities” was first reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at

Trilogy International Partners Company Profile

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with's FREE daily email newsletter.